0000000001323302

AUTHOR

S. Cascioferro

showing 5 related works from this author

PRC2 allosteric modulation an alternative strategy in drug discovery for the epigenetic diseases

2018

PRC2 epigenetic diseasea
researchProduct

Synthesis and antirpoliferative activity of isoxazolo[3,4-d]pyridazin-7(6H)-one derivatives

2014

3,4-diphenylisoxazolo[3,4-d]pyridazin-7(6H)-one analogs were synthesized and tested for the antiproliferative activity. Study on the cell cycle alteration and on some cellular target (ATM, procaspase-2 proteins and H2AX histone) demonstrate the increase of the cell population in S phase and to induce cellular death by apoptosis by DNA damage with double strand breaks.

Settore BIO/10 - Biochimicaisoxazolo[34-d]pyridazin-7(6H)-ones antiproliferative activity DNA interactionSettore CHIM/08 - Chimica Farmaceutica
researchProduct

Role of hypoxia in pemetrexed-resistance of mesothelioma mediated by proton-coupled folate transporter, and preclinical activity of new anti-LDH comp…

2018

Introduction There are few effective therapies for malignant pleural mesothelioma (MPM), which remains one of the most lethal cancers. We previously demonstrated that low expression of the PCFT transporter, both at mRNA and protein levels, is associated with shorter survival of MPM patients treated with pemetrexed (Giovannetti et al., 2017). Since hypoxia has also been associated to antifolate-resistance (Raz et al, 2014), this study was aimed at elucidating key factors in pemetrexed resistance and hypoxia that may contribute to the rational development of novel therapeutic interventions against mesothelioma. Methods The levels of PCFT and of the hypoxia marker carbonic anhydrase-IX were de…

proton-coupled folate transporter.Settore BIO/12 - Biochimica Clinica E Biologia Molecolare Clinicamesotheliomanew anti-LDH compoundmesothelioma; pemetrexed-resistance; new anti-LDH compounds; proton-coupled folate transporter.Settore BIO/14 - Farmacologiapemetrexed-resistanceSettore CHIM/08 - Chimica Farmaceutica
researchProduct

NUOVI DERIVATI 2-ACETAMMIDOBENZAMMIDICI: ATTIVITÀ ANTIPROLIFERATIVA E POSSIBILE MECCANISMO DI AZIONE

2014

Le cinnammido benzammidi rappresentano una classe di sostanze biologicamente attive di grande interesse farmaceutico. Nonostante siano state descritte per svariate attività biologiche, nessun dato è stato riportato sulla loro attivita antitumorale. Inizialmente una serie di 2-cinammidobenzammidi variamente sostituite sono state sintetizzate e valutate per la loro attività antiproliferativa. Partendo dal derivato risultato più attivo, il 2-cinnammido-5-iodobenzammide, che ha mostrato una percentuale di inibizione della crescita sulle K562 del 74% a 10μM, sono stati sintetizzati una serie di derivati al fine di approfondirne la SAR.I composti così ottenuti sono risultati attivi nei confronti …

Settore CHIM/08 - Chimica Farmaceuticacinnammido benzammidi antitumorali microtubuli
researchProduct

CCDC 644638: Experimental Crystal Structure Determination

2009

Related Article: D.Raffa, B.Maggio, S.Cascioferro, M.V.Raimondi, D.Schillaci, G.Gallo, G.Daidone, S.Plescia, F.Meneghetti, G.Bombieri, A.Di Cristina, R.M.Pipitone, S.Grimaudo, M.Tolomeo|2009|Eur.J.Med.Chem.|44|165|doi:10.1016/j.ejmech.2008.03.023

Space GroupCrystallographyCrystal SystemCrystal Structure3-Amino-N-(4-(benzyloxy)phenyl)-1H-indazole-1-carboxamideCell ParametersExperimental 3D Coordinates
researchProduct